Related Experiment Video
Updated: Feb 19, 2026

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals
Published on: May 30, 2013
Anti-HIV Passive Immunization: New Weapons in the Arsenal
1Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio, TX, USA; Southwest National Primate Research Center, San Antonio, TX, USA.
Abstract:
Anti-HIV passive immunization with human neutralizing monoclonal antibodies (nmAbs) has made exciting gains: (i) identification of the HIV envelope V2 apex as a new in vivo protective epitope, (ii) a novel clade C SHIV for challenge studies, and (iii) a highly protective, trispecific nmAb. Potent, broad-spectrum protection by nmAbs holds promise.
Related Concept Videos
Active versus Passive Immunity
Active Immunity
Active immunity refers to the resistance one develops...
Retrovirus Life Cycles
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cross-reactivity
Sexually Transmitted Infections

